Skip to content

Role of simultaneous use of patients own serum along with antifungal medicines in fungal corneal ulcer healing

Role of Adjuvant Autologous Serum in Fungal Corneal Ulcer Healing: A Randomized Controlled Trial - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100300
Enrollment
40
Registered
2026-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H160- Corneal ulcer

Interventions

Intervention1: There will be two groups in the study. Group A will be treated with standard of care and Group B will be treated with Autologous eye drops in addition to standard of care: Group A wil

Sponsors

PGIMER Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: KOH stain positive corneal ulcers,Mild to moderate in severity will be included in the study

Exclusion criteria

Exclusion criteria: Bacterial and mixed corneal ulcers,Ulcers warranting immediate surgical intervention (impending perforation/ perforated ulcer)Endophthalmitis,Known allergy to study medications ,Previous keratoplasty in involved eye Unwilling or unable to participate or follow up,Pregnant or breast-feeding females,Clinical evidence of herpetic keratitis,Age less than 16 years,Hepatitis B, C, HIV and Syphilis patients will be excluded from the study

Design outcomes

Primary

MeasureTime frame
Time to re-epithelisationTimepoint: Outcome will be assessed on day 3, 7, 14, 21, 30,60 and 90.

Secondary

MeasureTime frame
Best spectacle-corrected visual acuity at 3 months Infiltrate size or scar size Ulcer depth Time to ulcer healing No of eyes requiring surgical procedures cyanoacrylate glue adhesive or therapeutic penetrating keratoplasty or Amniotic Membrane Transplant. Timepoint: Patients will be assessed on day 0, 3, 7, 14, 21, 30,60 & 90. Outcome will be recorded at 3 months.

Countries

India

Contacts

Public ContactDr Indu Bala

Advanced Eye Centre, Department Of Ophthalmology, PGIMER, Chandigarh

pcgpgi@gmail.com9876764629

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026